Molecular cloning and characterisation of a mouse gene encoding an isoform of the neuronal cyclin-dependent kinase 5 (CDK5) activator

被引：9

作者：

Nildén, F ^{[1
]}

Bäckström, A ^{[1
]}

Bark, C ^{[1
]}

机构：

[1] Univ Uppsala, BMC, Dept Dev Neurosci, S-75123 Uppsala, Sweden

来源：

BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION | 1998年 / 1398卷 / 03期

关键词：

CDK5; activator; Cdc2-like protein kinase; neuronal protein; p35; p39; gene;

D O I：

10.1016/S0167-4781(98)00073-6

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

We have isolated and characterised the mouse gene for the p39 activator, designated p39is, which encodes a protein of 369 amino acids. The mouse p39 protein exhibits 95% amino acid identity to a previously characterised human p39 cDNA and the novel gene sequence corresponds to a single genomic locus in mouse. The p39is mRNA is highly expressed in the mouse central nervous system. (C) 1998 Elsevier Science B.V. All rights reserved.

引用

页码：371 / 376

页数：6

共 50 条

[41] Cyclin-Dependent Kinase 5 (CDK5) Mediates Degradation of Kruppel-like Factor 5 (KLF5)
Kim, Julie
de Sabando, Ainara Ruiz
Yang, Vincent W.
Bialkowska, Agnieszka
GASTROENTEROLOGY, 2016, 150 (04) : S522 - S523
[42] Cloning of three novel neuronal Cdk5 activator binding proteins
Ching, YP
Qi, Z
Wang, JH
GENE, 2000, 242 (1-2) : 285 - 294
[43] Prenatal cocaine and morphine alter brain cyclin-dependent kinase 5 (Cdk5) activity in rat pups
Bhat, Rama
Chari, Gopal
Rao, Ravi
Wirtshafter, David
NEUROTOXICOLOGY AND TERATOLOGY, 2006, 28 (05) : 625 - 628
[44] Cyclin-dependent kinase 5 (cdk5) activation requires interaction with three domains of p35
Amin, ND
Albers, W
Pant, HC
JOURNAL OF NEUROSCIENCE RESEARCH, 2002, 67 (03) : 354 - 362
[45] Control of cyclin-dependent kinase 5 (Cdk5) activity by glutamatergic regulation of p35 stability
Wei, FY
Tomizawa, K
Ohshima, T
Asada, A
Saito, T
Nguyen, C
Bibb, JA
Ishiguro, K
Kulkarni, AB
Pant, HC
Mikoshiba, K
Matsui, H
Hisanaga, S
JOURNAL OF NEUROCHEMISTRY, 2005, 93 (02) : 502 - 512
[46] Cyclin-dependent kinase 5 (Cdk5): A potential therapeutic target for the treatment of neurodegenerative diseases and diabetes mellitus
Wei, Fan-Yan
Tomizawa, Kazuhito
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2007, 7 (10) : 1070 - 1074
[47] Activation of latent cyclin-dependent kinase 5 (Cdk5)-p35 complexes by membrane dissociation
Zhu, YS
Saito, T
Asada, A
Maekawa, S
Hisanaga, S
JOURNAL OF NEUROCHEMISTRY, 2005, 94 (06) : 1535 - 1545
[48] Cyclin dependent kinase 5 (Cdk5) and its function in Hepatocellular carcinoma
Liebl, J.
Stamm, S.
Guenther, M.
Mayr, D.
Kirchner, T.
De Toni, E. N.
Vollmar, A.
Zahler, S.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2012, 385 : 53 - 53
[49] Mouse cyclin-dependent kinase (Cdk) 5 is a functional homologue of a yeast Cdk, Pho85 kinase
Nishizawa, M
Kanaya, Y
Toh-e, A
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (48) : 33859 - 33862
[50] Functional domains of p35 that activate neuronal cyclin dependent kinase-5 (CDK5)
Amin, ND
Pant, HC
FASEB JOURNAL, 1997, 11 (09): : A1184 - A1184

← 1 2 3 4 5 →